- Biotechnology
- Tuesday, 25 Feb 2020
Hansa Biopharma to Participate in Two Upcoming Investor Conferences
Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, announced that the Company's management team will participate in the following upcoming investor conferences:
- Cowen and Company's 40th Annual Health Care Conference in Boston on Monday, March 2, 2020, with a presentation at 4:10 PM EST/ 22:10 CET on the same day.
- The Carnegie Nordic Healthcare Seminar in Stockholm on Wednesday, March 4, 2020, with a presentation at 8:00 AM CET
A live webcast of the Cowen presentation will be available on the Events & Webcast page of the Company's website, www.hansabiopharma.com . A replay of the presentation will be available approximately two hours after the event and will be available for two weeks following the presentation.
Calendar 2020
| Feb 27-28, 2020 | Road Show Cowen, Chicago/Dallas |
| Mar 2, 2020 | Cowen Annual Health Care Conference, Boston |
| Mar 4, 2020 | Road Show Argot, New York City |
| Mar 4, 2020 | Carnegie Nordic Healthcare Seminar, Stockholm |
| Mar 26, 2020 | Kempen Expert Call with Prof. Mårten Segelmark on Anti-GBM |
| Apr 2, 2020 | Annual Report 2019 |
| Apr 21-22, 2020 | Kempen Life Sciences Conference, Amsterdam |
| Apr 28, 2020 | Interim Report Jan-Mar 2020 |
| May 5, 2020 | Annual General Meeting |
| May 18, 2020 | UBS Global Healthcare Conference, NYC |
| May 19, 2020 | RBC Global Healthcare Conference, NYC |
| May 26, 2020 | ABG Life Science Summit, Stockholm |
| May 27, 2020 | Ökonomisk Ugebrev Life Science Conference, Copenhagen |
| Jul 16, 2020 | Interimn Report Jan-Jul 2020 |
| Sep 16-17, 2020 | Bank of America Merill Lynch Global Healthcare Conf., London |
| Oct 22, 2020 | Interimn Report Jan-Sep 2020 |
Related Industry Updates
North America Drug Modelling Software Market Insights, Trends Sales, Supply, Demand 2020 to 2027
Apr 01, 2021
CordenPharma & Moderna Extend Strategic Manufacturing Services Agreement for the Supply of Lipid Excipients to be used in Moderna's Vaccine (mRNA-1273) Against the Novel Coronavirus SARS-CoV-2
May 28, 2020
Asia Pacific Eye Health Supplement Market Set to Record Exponential Growth by 2027
Nov 24, 2020
North America Human Microbiome Market Study Offering Deep Insight Related to Growth Trends Until 2025
Aug 13, 2020
Congestive Heart Failure Treatment Device Market Is Rising With Post COVID-19 Impact Analysis, Development, CAGR , Forecast To 2021-2027
Apr 19, 2021
Healthcare Specialty Enzymes Market 2020: Global Industry Share, Demand, Revenue, Size, Trends, Development, Opportunity, Growth Factors, Gross Margin, Major Companies, Value Chain, and 2027 Forecast
Jan 05, 2021
Neuritek Therapeutics secures a capital commitment of 25 million euros from Gem Group
Mar 31, 2020